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increase in end-diastolic pressure. Using simultaneous Doppler echo- 
cardiographic%d apexcardiographic recordings, we have previously 
reported (3,4) that in patients with coronary and hypertensive heart 
disease, a decreased peak A flow velocity is most frequently associated 
with a significantly elevated apexcardiographic A wave height. Accord- 
ing to our data, atria1 systolic function, which is given by the “gener- 
ation of pressure” and assessed by the relative height of the apexcar- 
diographic A wave, is not decreased but significantly increased in such 
patients. Consequently, the decrease in flow through the mitral valve 
during atria1 contraction in this clinical setting does not reflect a 
diminished power of atrial contraction; rather. it is the result of 
elevated ventricular tilling pressures only. Thus, “true atria1 function” 
can be evaluated only by an additional assessment of the power of 
“pressure generation” and the resulting “atrial kick” by the use of 
apexcardiographic recordings. These alternative fundamental patho- 
physiologic aspects, which have been extensively analyzed by many 
investigators using various techniques, were entirely neglected by 
Manning et al. By excluding these important data from the interpre- 
tation and discussion of their findings, the authors arrived at false 
conclusions about the nature and definition of atria1 function itself. 
A combined Doppler echocardiographic and apexcardiographic A 
wave index would probably help greatly in providing a clinically useftil 
evaluation of “true atrial function.” Such an index could be. for 
example, the ratio of the relative A wave to total height of apexcar- 
diogram and the peak A flow velocity; the former provides information 
about the force of “pressure generation” and the latter about the 
“change in flow” during atrial contraction. 
We hope that our previous work using both Doppler (flow) and 
apexcardiographic (pressure) A waves will stimulate the development 
of such combined indexes for accurately evaluating the “true atrial 
function and performance,” which can only be assessed when both 
parts of the equation are given. 
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In our report (1) we define atlial ejection force as “that force exerted 
by the left atrium in propelling blood into the left ventricle during 
atria1 systole . . . and should not be misinterpreted as an assessment of 
‘total’ atrial force.” Total atrial force would be the vector sum of all 
forces acting within the atrium. Utilizing echocardiographic variables, 
atrial ejection force is prc=ortional to peak A velocity squared. 
We agree that peak A velocity is frequently elevated among 
patients with heart disease. Because pe%k A velocity may be increased 
among patients with coronary and hypertenswe heart disease, one 
would then have expected atria1 ejection force to be increased in the 
study group (compared with control subjects), yet it was significantly 
depressed after cardioversion and continued for at !east I week after 
cardioversion. With each patient used as their own control, atrial 
ejection force significantly increased during the succeeding period of 
observation. To explain our findings on the basis of changes in filling 
pressure alone, one wuiild ha-e to hypothesize that left atrial filling 
pressure increased during the month after cardioversion. It is more 
likely that filling pressures declined (2). Thus, through the use of 
longitudinal data, we are comfortable in aarming the validity of atrial 
ejection force as an index of atria1 systolic function. We are unaware of 
serial apexcatdiogtaphic data among patients undergoing cardiover- 
sion and cannot be certain how this variable would change. Because 
the height of the apexcardiographic A wave is more closely related to 
ventricular stiffness, end-diastolic pressure and the volume 0: atrial 
sys!olic flow, concordance between it and atrial ejection force may be 
limited. 
We fully appreciate that “transmitral Doppler data alone do not 
fully reflect changes in ventricular compliance and . . a less compliant 
ventricle might present greater resistance to transmitral inflow and 
result in a depressed peak A wave velocity” (1). Better models are 
indeed needed, but because of the complexity of left ventricular 
diastolic and left atrial systolic function, one must carefully identify 
which components of cardiac performance are being assessed. 
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IIeparin and Aspirin in Unstable Angina: 
Insuficient Sample Size May Lead to 
Erroneous Conclusions 
In their article, Holdright et al. (1) address the interesting question 
whether, in patients with unstable angina, heparin combined wifh 
apirin is more effective in preventing transient myocardial ischemia 
than aspirin alone. The authors attack the current standard of practice 
in the United States, which is to use both aspirin and heparin (2). The 
authors, therefore. have the burden of proof. 
Holdright et ai. conclude that ‘-combined therapy with heparin and 
aspirin compared with aspirin aione makes no difference in the 
development of [transient myocardial ischemia].” Strikingly. their data 
shown in Table 2 (1) suggest just the opposite. The number of patients 
with at least one episode of transient mycc&rdial ischemia was 2% less 
in the heparin plus aspirin group than in the aspirin alone group, 18% 
vs. 24% of patients, respectively. Even more strikingly, this pattern was 
consistent in every single variable presented by the authors. The total 
number of episodes in the heparin plus aspirin group was less by 354, 
the median duration of episodes shorter by 16%; the total duration of 
